Foreign companies keen to tie up with Indian pharma
Several foreign companies are willing to tie-up with Indian pharmaceutical companies. As Ambassadors of 100 countries arrived in Pune near Mumbai over the weekend to visit the Serum Institute of India and Gennova Biopharma facility, many have expressed keen interest.
India's Central Drug Standard Control Organization has granted permission for the manufacture of COVID-19 vaccine for pre-clinical test, examination and analysis to seven firms, two of which are Serum Institute of India (SII) and Gennova Biopharmaceuticals.
The SII is involved in the AstraZeneca (LSE: AZN)/Oxford University vaccine against COVID-19, while Gennova is working on an mRNA-based vaccine.
Sweden has already acknowledged India’s role as the 'pharmacy of the world' and is focusing on expanding bilateral cooperation in the areas of pharma and life sciences.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
More on this story...
Today's issue
Company Spotlight
More Features in Pharmaceutical
| Headless Content Management with Blaze